See What HealthDay Can Do For You
Contact Us

Transvaginal Mesh Surgery Restores Pelvic Organ Prolapse

Improvement for pre-and postmenopausal, but dyspareunia worsens in premenopausal women

THURSDAY, June 9 (HealthDay News) -- Transvaginal mesh (TVM) surgery is effective in treating pelvic organ prolapse (POP) in both pre- and postmenopausal women but dyspareunia may worsen in premenopausal women, according to a study published online May 23 in the Journal of Sexual Medicine.

Cheng-Yu Long, M.D., Ph.D., from Kaohsiung Medical University in Taiwan, and colleagues compared the changes in sexual function of premenopausal and postmenopausal women after TVM surgery. A total of 68 sexually active women, categorized as premenopausal (36) and postmenopausal (32), with symptomatic POP stages II to IV were referred for TVM surgery. Preoperative and postoperative assessments included pelvic examination using the POP quantification (POP-Q) system, and completing the Female Sexual Function Index (FSFI), Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7).

The investigators found significant improvement in the POP-Q analysis at points Aa, Ba, C, Ap, and Bp in both groups but not in total vaginal length. The UDI-6 and IIQ-7 scores decreased significantly after TVM surgery. The dyspareunia domain score decreased significantly after surgery only in the premenopausal group. Reports of diminished scores of the dyspareunia domain and total scores were more common among women in the premenopausal group, but there were no significant differences in FSFI domains or total scores between the groups.

"The results of our study suggest that the TVM procedure is effective for the anatomical correction of POP," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing